[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100610775":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":30,"centralContacts":34,"locations":40,"responsibleParty":53,"collaborators":25,"id":56,"slug":25,"hasResults":57,"nctId":58,"briefTitle":59,"officialTitle":60,"acronym":25,"eligibilityCriteria":61,"healthyVolunteers":57,"sex":62,"minAge":63,"maxAge":64,"enrollmentInfo":65,"targetDuration":25,"studyType":68,"phases":69,"briefSummary":72,"conditions":73,"keywords":25,"overallStatus":75,"whyStopped":25,"lastUpdateSubmitDate":76,"lastUpdatePostDateStruct":77,"startDateStruct":80,"completionDateStruct":82,"leadSponsor":84,"locationsCount":85},{"fullName":5,"class":6},"Mayo Clinic","OTHER",[8,15],{"label":9,"type":10,"description":11,"interventionNames":12},"Dronabinol Group","ACTIVE_COMPARATOR","Patients taking Dronabinol first and Placebo second",[13,14],"Drug: Dronabinol","Drug: Placebo",{"label":16,"type":10,"description":17,"interventionNames":18},"Placebo Group","Patients taking Placebo first and Dronabinol second",[13,14],[20,26],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"DRUG","Dronabinol","Patients will take one 10 mg dose of Dronabinol.",[9,16],null,{"type":21,"name":27,"description":28,"armGroupLabels":29,"otherNames":25},"Placebo","Patients will take one 10mg dose of a Placebo Pill.",[9,16],[31],{"name":32,"affiliation":5,"role":33},"Virend Somers","PRINCIPAL_INVESTIGATOR",[35],{"name":36,"role":37,"phone":38,"phoneExt":25,"email":39},"Nicholas Wozniak","CONTACT","507-255-8794","wozniak.nicholas@mayo.edu",[41],{"facility":42,"status":25,"city":43,"state":44,"zip":45,"country":46,"cosmosGeoPoint":47,"geoPoint":52,"contacts":25},"Mayo Clinic in Rochester","Rochester","Minnesota","55905","United States",{"type":48,"coordinates":49},"Point",[50,51],-92.4699,44.02163,{"lat":51,"lon":50},{"type":33,"investigatorFullName":54,"investigatorTitle":55,"investigatorAffiliation":5,"oldNameTitle":25,"oldOrganization":25},"Virend Somers, MD, PhD","Principal Investigator","100610775",false,"NCT07231965","Synthetic THC And Blood Pressure","Effects Of Cannabis Products On Blood Pressure Control","Inclusion Criteria\n\n* Recreational occasional Cannabis use (Consuming THC less than 2 times a week)\n* 21 - 40 years of age\n* Biological male or female\n\nExclusion Criteria\n\n* BMI \\> 35 kg\u002Fm2\n* Diagnosed psychiatric disorders\n* Hypotension\n* History of seizures\n* History of substance abuse or recreational drug use or positive urine drug screen\n* History of uncontrolled disease including:\n\n  * Cardiovascular\n  * Pulmonary\n  * Gastrointestinal\n  * Pancreatic\n  * Hepatic\n  * Renal\n  * Hematological\n  * Endocrine (including Type I Diabetes)\n  * Neurological\n  * Urological\n  * Sleep disorders\n* Pregnant or breastfeeding\n* Use of certain antimicrobial, chemotherapeutic, anticoagulant, hypoglycemic, anti-inflammatory, psychotropic, and antihistamine drugs\n* Prescribed CYP2C9 and\u002For CYP3A4 inhibitors\n* History of shift work or rotating shifts within 1 month","ALL","21 Years","40 Years",{"count":66,"type":67},50,"ESTIMATED","INTERVENTIONAL",[70,71],"PHASE2","PHASE3","To investigate the effects of Dronabinol use on blood pressure and neurovascular physiology",[74],"Blood Pressure","NOT_YET_RECRUITING","2026-05-05",{"date":78,"type":79},"2026-05-07","ACTUAL",{"date":81,"type":67},"2026-07",{"date":83,"type":67},"2027-12",{"name":5,"class":6},1]